Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | MMP1 | P03956 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | MMP9 | P14780 | 2/20 | 0.35 |
| ▸ | MMP8 | P22894 | 2/20 | 0.35 |
| ▸ | MMP13 | P45452 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5307190 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL3175397 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL7640246 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1038814 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL1830499 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL11588704 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL970482 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL15641245 | 1.00 | LMNA (0.42) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL31548819 | 0.97 | LMNA (0.40) | LMNATHRBCA2CA1MMP1 | |
| SCHEMBL8617832 | 0.96 | LMNA (0.37) | LMNATHRBCA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260023052-A1 | METHOD FOR MEASURING CONCENTRATION OF PER- AND POLYFLUOROALKYL SUBSTANCE AND LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY SYSTEM | RESEARCH CENTER FOR ECO-ENVIRONMENTAL SCIENCES, CHINESE ACADEMY OF SCIENCES (CN) | 2026-01-22 | — | — | US | disclosed |
| EP-4579235-A1 | METHOD FOR DETERMINATION OF CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES, AND LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY SYSTEM | Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences (CN) | 2025-07-02 | — | — | EP | disclosed |
| CN-110564280-A | Double-component fluorine-containing hydrophobic coating and preparation and use methods thereof | 国电新能源技术研究院有限公司 | 2019-12-13 | — | — | CN | disclosed |
| EP-1703327-B1 | Composition for forming antireflection film, laminate, and method for forming resist pattern | JSR CORP (JP) | 2011-05-11 | — | — | EP | disclosed |
| EP-1703327-A2 | Composition for forming antireflection film, laminate, and method for forming resist pattern | JSR Corporation (JP) | 2006-09-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260023052-A1 | METHOD FOR MEASURING CONCENTRATION OF PER- AND POLYFLUOROALKYL SUBSTANCE AND LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY SYSTEM | PFAS, SRMS, PHOSPHO1 | LMNA 2238/4885THRB 3029/4885CA2 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.